NEWS RELEASE 4/7/17 2:20PM EST WTF DOES THIS MEAN? LOL MELANIE LAINE SKIDMORE
21476 76 Avenue
Langley, BC V2Y 2E8
FOR IMMEDIATE RELEASE:
SHAREHOLDER NEWS RELEASE
Vancouver, Canada – April 7, 2017 – Melanie Laine Skidmore (the “Shareholder”) issues this early warning news release in respect of her security holdings of Ventripoint Diagnostics Ltd. (TSXV: VPT) (the “Issuer”).
On April 6, 2017, the Shareholder sold 617,890 common shares of the Issuer through the TSX Venture Exchange (the “Exchange”) at prices ranging from $0.42 - $0.44 per share, and on April 5, 2017, the Shareholder sold 474,000 common shares of the Issuer through the Exchange at prices ranging from $0.43 - $0.45 per share, and on April 4, 2017, the Shareholder sold 274,500 common shares of the Issuer through the Exchange at $0.45 per share. The foregoing shares (collectively, the “Shares”) represent approximately 2.7% of the Issuer’s current issued and outstanding common shares.
As a result of the sale of the Shares, the Shareholder holds or exercises shared control or direction over a total of 3,155,282 common shares of the Issuer as at the close of business on April 6, 2017, representing approximately 6.3% of the current issued and outstanding shares of the Issuer, and share purchase warrants to purchase 1,392,045 common shares of the Issuer. Assuming the exercise in full of the share purchase warrants, the number of common shares held by the Shareholder or over which she exercises shared control or direction represents approximately 9% of the current issued and outstanding common shares of the Issuer.
This news release is being disseminated pursuant to National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues (“NI 62-103”). A copy of the report to be filed with Canadian securities regulators in connection with the acquisition of these securities can be obtained upon its filing under the Issuer’s profile on the SEDAR website (www.SEDAR.com) or by contacting Ron Paton of Owen Bird Law Corporation at 604 691 7504.